Efforts to fuel AI's ravenous appetite for power have seen some big technology companies ink deals in the nuclear sector this year -- Alphabet's Google, Amazon and Microsoft. Developers of small ...
Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.
Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...